Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Exchange Rate Effect (2016 - 2025)

CorMedix's Exchange Rate Effect history spans 11 years, with the latest figure at $276.0 for Q3 2025.

  • For Q3 2025, Exchange Rate Effect fell 33.49% year-over-year to $276.0; the TTM value through Sep 2025 reached -$189.0, down 110.47%, while the annual FY2024 figure was -$2000.0, 171.23% down from the prior year.
  • Exchange Rate Effect for Q3 2025 was $276.0 at CorMedix, down from $828.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $15787.0 in Q4 2022 and bottomed at -$10909.0 in Q3 2022.
  • The 5-year median for Exchange Rate Effect is -$446.5 (2024), against an average of -$1248.7.
  • The largest annual shift saw Exchange Rate Effect plummeted 438.75% in 2022 before it surged 1040.91% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$3120.0 in 2021, then skyrocketed by 605.99% to $15787.0 in 2022, then crashed by 85.53% to $2284.0 in 2023, then crashed by 166.64% to -$1522.0 in 2024, then surged by 118.13% to $276.0 in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Exchange Rate Effect are $276.0 (Q3 2025), $828.0 (Q2 2025), and $229.0 (Q1 2025).